Skip to main content

News and Events

Stay up-to-date about
RECOVER

News and Updates

Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.

28 Results

Filters

28 Results

Filters Applied:

Expert committee proposes a new working definition of Long COVID

The National Academies of Sciences, Engineering, and Medicine (NASEM) recommends that researchers, healthcare professionals, and government agencies adopt its new working definition of Long COVID to help ease the suffering of millions of people.

Announcement

RECOVER researchers publish pediatric study design

The journal PLOS ONE has published the full RECOVER study design for babies, children, adolescents, and young adults taking part in RECOVER studies.
Observational Tissue Pathology Adult Pediatric Pregnant Adult
Announcement

NIH to open Long COVID clinical trials to study sleep disturbances, exercise intolerance, and post-exertional malaise

RECOVER-ENERGIZE and RECOVER-SLEEP will test multiple treatments for sleep disturbances, difficulties exercising, and worsening Long COVID symptoms after physical, mental, or emotional activity.

Clinical Trial Adult
News Release

NIH RECOVER makes Long COVID research data easier to access

Deidentified data from thousands of adults with Long COVID are now available to researchers.
Observational Adult
News Release

NIH opens Long COVID trials to evaluate treatments for autonomic nervous system dysfunction

RECOVER-AUTONOMIC will test at least three treatments for symptoms such as fast heart rate, dizziness and fatigue.
Clinical Trial Adult
News Release

NIH to bolster RECOVER Long COVID research efforts through infusion of $515 million

This additional funding will build on and continue RECOVER's work to improve our understanding of and ability to diagnose, prevent, and treat Long COVID.

Clinical Trial EHR Observational Pathobiology Tissue Pathology Adult Pediatric Pregnant Adult
News Release

Leadership Q&A: NIH to bolster RECOVER Long COVID research efforts

Gary Gibbons, M.D., Walter Koroshetz, M.D., and Jeanne Marrazzo, M.D., M.P.H. of the NIH answer questions about investing an additional $515 million in RECOVER's Long COVID research efforts.

Clinical Trial EHR Observational Pathobiology Tissue Pathology Adult Pediatric Pregnant Adult
Q&A

Now Available: Dataset for “Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection”

Authorized researchers may request access to the dataset, which contains more than 3.3 million de-identified data entries and a Data Dictionary.
Observational Adult
Announcement

Media Inquiries

Are you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.

Back to Top